SLU-PP-332 is a synthetic pan-agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ — orphan nuclear receptors that master-regulate mitochondrial biogenesis, oxidative phosphorylation, and fatty acid β-oxidation. It is studied as a pharmacological exercise mimetic due to its ability to activate PGC-1α-related transcriptional programs in skeletal muscle.
Research Applications:
- Mitochondrial biogenesis and PGC-1α pathway studies
- Exercise mimetics and endurance physiology research
- Fatty acid oxidation and metabolic flexibility models
- Skeletal muscle fiber type switching research
- Cardiac and neuronal energetics studies
Key Properties:
Targets: ERRα, ERRβ, ERRγ (pan-agonist)
Molecular Formula: C₂₄H₂₂FN₃O₃S
Molecular Weight: 455.5 Da
CAS: 2767884-32-6
Product Specifications:
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: −20 °C, protected from light
For research use only. Not for human consumption. Not for veterinary use. No medical or therapeutic claims are made. These statements have not been evaluated by the FDA.

Reviews
There are no reviews yet.